Diabetes Care 43(9):21372145
Thats the only safe route
This review synthesizes the cellular and physiological mechanisms, contrasts incretin-based therapies with lipid-lowering pharmacotherapy, summarizes the principal randomized trials, evaluates the distinction between plaque regression and plaque stabilization, and outlines unresolved questions and clinical-implementation considerations
Likewise, glucosinolate metabolites, particularly sulforaphane, may exert a beneficial effect on neurological and psychiatric conditions, such as depression, schizophrenia, autism, Alzheimers disease, and multiple sclerosis
Any quality prebiotic fiber (resistant starch, psyllium, beta-glucan) provides the same mechanism at lower cost